SCANPHARM A/S: Financial statements 2014
CVR: 16279099
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 20,769,828 and a net result of DKK 431,209 compared with DKK 399,646 the year before. That is a decrease of 0.9% compared with the year before. Equity in the 2014 report amounted to DKK 10,988,995. The solvency ratio was 32.6%.
- Gross Profit
- DKK 20,769,828
- Profit/Loss
- DKK 431,209
- Equity
- DKK 10,988,995
- Total Assets
- DKK 33,666,506
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
| 2013 | - | 20.9 mio. | 400 t. | 10.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
SCANPHARM A/S has published its annual report for 2013. Gross profit came to DKK 20,949,478, and the net result was DKK 399,646.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.